ATE207479T1 - Kristalle von derivaten von chinozon carbonsäure- hydraten - Google Patents

Kristalle von derivaten von chinozon carbonsäure- hydraten

Info

Publication number
ATE207479T1
ATE207479T1 AT93902548T AT93902548T ATE207479T1 AT E207479 T1 ATE207479 T1 AT E207479T1 AT 93902548 T AT93902548 T AT 93902548T AT 93902548 T AT93902548 T AT 93902548T AT E207479 T1 ATE207479 T1 AT E207479T1
Authority
AT
Austria
Prior art keywords
carboxylic acid
chinozone
crystals
derivatives
acid hydrates
Prior art date
Application number
AT93902548T
Other languages
English (en)
Inventor
Hiroyuki Nagano
Nobuyuki Suzuki
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE207479T1 publication Critical patent/ATE207479T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT93902548T 1992-01-31 1993-01-29 Kristalle von derivaten von chinozon carbonsäure- hydraten ATE207479T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1654592 1992-01-31
PCT/JP1993/000109 WO1993015070A1 (fr) 1992-01-31 1993-01-29 Cristal d'hydrate de derive d'acide quinolonecarboxylique

Publications (1)

Publication Number Publication Date
ATE207479T1 true ATE207479T1 (de) 2001-11-15

Family

ID=11919237

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93902548T ATE207479T1 (de) 1992-01-31 1993-01-29 Kristalle von derivaten von chinozon carbonsäure- hydraten

Country Status (8)

Country Link
US (1) US5597923A (de)
EP (1) EP0629621B1 (de)
KR (1) KR100228572B1 (de)
AT (1) ATE207479T1 (de)
CA (1) CA2128601C (de)
DE (1) DE69331003T2 (de)
ES (1) ES2167329T3 (de)
WO (1) WO1993015070A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008967A1 (fr) * 1992-10-09 1994-04-28 Chugai Seiyaku Kabushiki Kaisha Derive de fluoroquinoleine
CA2201735A1 (en) * 1994-11-18 1996-05-30 The Upjohn Company A new physically stable solid form of a fluoroquinolone
JP3449658B2 (ja) * 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
GB0026490D0 (en) * 2000-10-30 2000-12-13 Pfizer Ltd Process
KR20040106518A (ko) * 2002-05-10 2004-12-17 테바 파마슈티컬 인더스트리즈 리미티드 가티플록사신의 신규한 결정 형태
US7423153B2 (en) 2002-05-10 2008-09-09 Teva Pharmaceutical Industries Ltd. Crystalline forms of gatifloxacin
EP1645274A1 (de) * 2002-05-10 2006-04-12 Teva Pharmaceutical Industries Ltd. Verfahren zur Herstellung von Gatifloxacinform Omega
EP1471911A1 (de) 2002-06-14 2004-11-03 Teva Pharmaceutical Industries Ltd. Neue kristalline formen von gatifloxacin
JP2006508909A (ja) * 2002-08-06 2006-03-16 テバ ファーマシューティカル インダストリーズ リミティド ガチフロキサシンの新規な結晶形
WO2005012285A1 (en) * 2003-08-05 2005-02-10 Matrix Laboratories Ltd An improved process for the preparation of moxifloxacin hydrochloride
US7781585B2 (en) 2004-06-04 2010-08-24 Matrix Laboratories Ltd Crystalline forms of Gatifloxacin
US7594151B2 (en) * 2004-06-18 2009-09-22 Qualcomm, Incorporated Reverse link power control in an orthogonal system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
JPS63198664A (ja) * 1986-03-31 1988-08-17 Sankyo Co Ltd キノロンカルボン酸誘導体
JPS6490184A (en) * 1987-09-30 1989-04-06 Sankyo Co Pyridonecarboxylic acids
JPH0395177A (ja) * 1988-05-19 1991-04-19 Chugai Pharmaceut Co Ltd 新規キノロンカルボン酸誘導体

Also Published As

Publication number Publication date
CA2128601A1 (en) 1993-08-05
WO1993015070A1 (fr) 1993-08-05
EP0629621A1 (de) 1994-12-21
CA2128601C (en) 2003-07-15
DE69331003T2 (de) 2002-06-20
EP0629621A4 (de) 1995-02-01
KR100228572B1 (ko) 1999-11-01
KR950700281A (ko) 1995-01-16
US5597923A (en) 1997-01-28
DE69331003D1 (de) 2001-11-29
EP0629621B1 (de) 2001-10-24
ES2167329T3 (es) 2002-05-16

Similar Documents

Publication Publication Date Title
YU49312B (sh) Kristalni hidratni derivati 3,4,4-trisupstituisanih - peperidinil-n-alkilkarboksilata, njihovi intermedijari i postupak za dobijanje
ATE176474T1 (de) Cyclohexan-derivate, sie enthaltende zusammensetzungen und ihre verwendung
NO902954D0 (no) Fremgangsmaate for fremstilling av substituerte kinazolinoner som angitensin ii-antagonister.
ATE168373T1 (de) Benzofuranyl- und thiophenylalkancarbonsäurederivate
SE8406585D0 (sv) Benzoic acid derivatives
ID1018B (id) N-tersier-butil-dekahidro-2(3-amino-2-hidroksi-4-fenil-butil) isokinolin-3-karboksamida dan turunan-turunan asparaginil darinya
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
ATE415394T1 (de) Zwischeprodukte zur herstellung von retroviralen protease-hemmern
DE69331003D1 (de) Kristalle von derivaten von chinozon carbonsäure-hydraten
DK506587A (da) Imidderivater
FI920732A0 (fi) 2-substituerade kinoliner, foerfarande foer framstaellning av dessa och anvaendning av dessa i laekemedel.
NO931482D0 (no) Farmasoeytiske sammensetninger inneholdende quinolin- og quinazolinderivater og nye forbindelser for disse
DE3882895D1 (de) Imid-derivate, ihre herstellung und verwendung.
DE3782347D1 (de) Hetaryl-oxy-beta-carbolinderivate, ihre herstellung und verwendung als arzneimittel.
DE58905079D1 (de) Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung.
TR200402776T4 (tr) Nöraminik asit bileşiğinin hidratları ve bunların kristal biçimleri.
ATE160146T1 (de) Hetero-tricyclisch-substituierte phenyl- cyclohexan-carbonsäurederivate
ATE183502T1 (de) Octahydro-2-naphthalincarbonsäure-derivate, ihre herstellung und verwendung
ATE108783T1 (de) 2-imino-6-polyfluoralkyl-3-heterocyclylalkyl- benzothiazolinderivate, ihre herstellung und sie enthaltende arzneimittel.
JPS6470580A (en) Langmuir-blogett film and optical modulation element using same
FI922482L (fi) Foerfarande foer framstaellning av kinolinfoerening.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee